CD34 and acute myeloid leukemia: To confirm this result we overlapped the gene expression changes in the three FLT3i-treated patient samples at relapse after filtering for AML-specific genes by selecting genes >2-fold upregulated in at least one of the patient samples compared to a previously published RNA-Seq data from CD34+ cells from peripheral blood1 (Figure 1D).